CEO Letter Regarding COVID-19
As the COVID-19 pandemic continues to spread across the globe, NCGS continues to face these challenges to address study conduct continuity. Quarantine and restricted travel are among these challenges. Our number one priority remains focused on the health and safety of participants, site staff, and monitoring personnel involved in these trials. We strive to [...]